UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                             ----------------------

                                    FORM 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

         Date of Report (Date of earliest event reported): May 23, 2008


                              IMMERSION CORPORATION
             (Exact name of registrant as specified in its charter)

                             ----------------------


       Delaware                       000-27969                 94-3180138
- ----------------------------   -----------------------      ------------------
(State or other jurisdiction   (Commission File Number)       (IRS Employer
   of incorporation)                                        Identification No.)


                             ----------------------


                                  801 Fox Lane
                           San Jose, California 95131
               (Address of principal executive offices) (Zip Code)


                             ----------------------

       Registrant's telephone number, including area code: (408) 467-1900


                                 Not Applicable
          (Former name or former address, if changed since last report)



Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act
    (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
    (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
    Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
    Exchange Act (17 CFR 240.13e-4(c))


Item 5.02     Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

     (e) On May 23, 2008, Immersion entered into an executive incentive plan for
fiscal 2008 (the "Bonus  Plan") with Richard  Vogel,  Senior Vice  President and
General  Manager,  Immersion  Medical.  The Bonus Plan is  intended to focus Mr.
Vogel on Immersion's revenue,  operating profit and gross margin goals and other
business objectives, and to reward achievement of those goals.

     Mr. Vogel's Bonus Plan provides for a target bonus amount of $144,472,  and
a maximum bonus amount of $290,388.

     The Bonus Plan provides for a discretionary multiplier ranging from 0.80 to
1.20, based on overall  performance.  Immersion's  Chief Executive  Officer will
determine the discretionary multiplier for Mr. Vogel.

     The actual bonus amount for Mr. Vogel is determined through measurements of
both Immersion's corporate  performance and Mr. Vogel's individual  performance.
Fifteen  percent (15%) of the bonus is determined by a matrix of varying  levels
of GAAP  adjusted  revenue and GAAP  adjusted  operating  profit (loss) that are
achieved by  Immersion  in fiscal 2008;  fifteen  percent  (15%) of the bonus is
determined by  achievement of a number of corporate  initiatives,  including the
consummation of a strategic  transaction that increases revenue and/or operating
income within certain specified parameters,  the implementation of an enterprise
resource planning system, increasing the percentage of Immersion's total revenue
that is  derived  from  international  sources  and  increasing  the  number  of
non-financial  or  administrative  press  releases  issued by Immersion in 2008;
fifty-two  and a half percent  (52.5%) of the bonus is determined by a matrix of
varying  levels of GAAP  adjusted  revenue and GAAP  adjusted  operating  profit
(loss) that are achieved by the Immersion  Medical business unit in fiscal 2008;
and  the  remaining  seventeen  and a  half  percent  (17.5%)  of the  bonus  is
determined by achievement of a number of individual  business unit  initiatives,
including the expansion of Immersion Medical's  international  team,  increasing
Immersion  Medical's  international  revenues,   supporting  Immersion's  patent
enforcement  activities  and  launching  certain new products  within  specified
timeframes.

     Payment of the cash  bonus  pursuant  to the Bonus  Plan is subject to Mr.
Vogel's  continued  employment  through the payment  date,  which is expected to
occur on the next  payroll  period after the later of: (a) 45 days after the end
of the fiscal  year;  (b) the date on which  Immersion's  income  statement  for
fiscal 2008 has been finalized,  or (c) the date on which  Immersion's  earnings
for fiscal 2008 have been  publicly  disclosed.  If Mr.  Vogel  resigns from his
employment  prior to the payment date, or his employment is terminated  prior to
the payment date, he will not earn any payment under the Bonus Plan.


     Pursuant to the  requirements  of the  Securities  Exchange Act of 1934, as
amended,  the  Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.


                                IMMERSION CORPORATION


Date: May 23, 2008              By: /s/ Stephen M. Ambler
                                    --------------------------------------------
                                    Stephen M. Ambler
                                    Chief Financial Officer and Vice President,
                                    Finance